Cassava Sciences, Inc.
SAVA
$2.05
-$0.07-3.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -15.81% | 37.92% | -25.11% | 147.96% | -26.61% |
| Gross Profit | 15.81% | -37.92% | 25.11% | -147.96% | 26.61% |
| SG&A Expenses | 18.19% | -123.83% | 228.51% | 1,113.34% | 52.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.88% | -13.67% | 13.79% | 113.37% | -13.50% |
| Operating Income | 5.88% | 13.67% | -13.79% | -113.37% | 13.50% |
| Income Before Tax | -193.45% | -31.92% | -8.94% | 123.34% | 203.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -193.45% | -31.92% | -8.94% | 123.34% | 203.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -193.45% | -31.92% | -8.94% | 123.34% | 203.18% |
| EBIT | 5.88% | 13.67% | -13.79% | -113.37% | 13.50% |
| EBITDA | 5.56% | 13.46% | -14.47% | -115.25% | 13.39% |
| EPS Basic | -183.26% | -15.71% | 4.63% | 121.11% | 200.15% |
| Normalized Basic EPS | -182.46% | 25.42% | 0.86% | 121.12% | 188.17% |
| EPS Diluted | -14.07% | -14.60% | 4.63% | 120.60% | 26.90% |
| Normalized Diluted EPS | -184.57% | 25.42% | 0.86% | 121.12% | 185.97% |
| Average Basic Shares Outstanding | 12.23% | 14.01% | 14.22% | 10.55% | 3.02% |
| Average Diluted Shares Outstanding | 9.43% | 14.01% | 14.22% | 10.55% | 5.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |